Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Oncternal Therapeutics To Discontinue Clinical Trials For ONCT-534 And ONCT-808 Due To Lack Of Clinically Meaningful Results And High Capital Requirements; Company To Explore Strategic Alternatives, Including Asset Sales, Licensing, Or Mergers While Reducing Workforce To Preserve Cash Resources

Author: Benzinga Newsdesk | September 12, 2024 08:01am

Posted In: ONCT